The Efficacy of Boric Acid Used to Treat Experimental Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: an In Vivo Study
- 9 March 2016
- journal article
- research article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 173 (2) , 384-389
Abstract
We explored the ability of local and systemic applications of boric acid (BA) to reduce the numbers of methicillin-resistant Staphylococcus aureus (MRSA) in a rat model of tibial osteomyelitis (OM), and compared boric acid with vancomycin (V). Implant-associated osteomyelitis was established in 35 rats. After 4 weeks, at which time OM was evident both radiologically and serologically in all animals, the rats were divided into five groups of equal number: group 1, control group (no local application of BA or other medication); group 2, V group; group 3, local BA + V group; group 4, local BA group; and group 5, local + systemic BA group. Serum total antioxidant status, and the levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6, were measured. Pathological changes attributable to bone OM were evaluated using a grading system. Bacterial colony-forming units (CFUs) per gram of bone were counted. The lowest bacterial numbers were evident in group 3, and the bacterial numbers were significantly lower than that of the control group in all four test groups (p < 0.001). Group 3 also had the least severe bone infection (OM score 1.7 ± 1.1, p < 0.05). Upon histological and microbiological evaluation, no significant difference was evident between groups 2 and 3. Total antioxidant levels were significantly different in all treatment groups compared to the control group. Microbiological and histopathological evaluation showed that systemic or local application of BA was effective to treat OM, although supplementary V increased the effectiveness of BA.Keywords
This publication has 31 references indexed in Scilit:
- BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trialTrials, 2015
- Chronic suppurative otitis media due to nontuberculous mycobacteria: A case of successful treatment with topical boric acidInternational Journal of Pediatric Otorhinolaryngology, 2015
- Effects of Boric Acid on Fracture Healing: An Experimental StudyBiological Trace Element Research, 2015
- Effects of Local Administration of Boric Acid on Posterolateral Spinal Fusion with Autogenous Bone Grafting in a Rodent ModelBiological Trace Element Research, 2015
- Local Application of Free Antibiotic Powder in the Treatment of Osteomyelitis in a Rat ModelOrthopedics, 2013
- Boron regulates mineralized tissue-associated proteins in osteoblasts (MC3T3-E1)Journal of Trace Elements in Medicine and Biology, 2010
- Comparison of various surgical methods in the treatment of implant-related infectionInternational Orthopaedics, 2009
- Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05Journal of Antimicrobial Chemotherapy, 2007
- Surgical management of chronic osteomyelitisThe American Journal of Surgery, 2004
- Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapyThe American Journal of Medicine, 2003